Introducing Liquid Single-Use Bags from ILC Dover
April 28th 2022ILC Dover announced its launch of liquid single-use bioprocessing bags, representing the first of many new products for handling sterile liquids in the biotherapeutics and cell and gene therapy markets. This expansion continues our line of solutions designed for use across the entire biotherapeutic and pharmaceutical manufacturing workflow—from powder containment and handling to sterile liquid handling and pre-filled liquid and powder bags.
Temperature Control for Chemical Research and Production v2
April 27th 2022Precise temperature control has a significant influence on performance and quality in chemical process engineering. The Unistat range of temperature control systems ensure accurate temperatures and stable process conditions in research laboratories, pilot plants and kilolabs worldwide.
Post-curing on the reduction of cyclosiloxanes v2
April 18th 2022Watson Marlow Fluid Technologies Solutions (WMFTS), fluid path solutions provider of peristaltic pumps and single-use component, outlines the results of a study which makes comparisons between the semi volatiles extractables profile of post-cured and non post-cured samples of its Pumpsil platinum-cured silicone tubing.
Improving Titer, Quality and Efficiency of AAV Manufacturing and Production by Optimizing Osmolality
April 13th 2022Modulating osmolality in the early stages of AAV1 upstream manufacturing, can result in improved outcomes such as overall yield, quality, reduced manufacturing costs and improved efficiencies.
New Octet® Bioprocessing Applications Page
March 25th 2022To accelerate commercialization of biotherapeutics, organizations need to optimize processes by integrating advanced analytical tools that maximize quality, safety, and efficacy. Octet® BLI systems enable real-time, label-free analysis for the determination of kinetics, affinity, and antibody/protein quantitation. Based on Bio-Layer Interferometry (BLI), the systems enable an enviable variety of applications throughout biologics development, from early selection to validation and manufacturing. Read on to learn about the implementation in the production of biotherapeutics for titer, host cell protein analysis, residual protein detection, sialic acid content detection, potency assay development, Fab activity assay development, and more.
Residual Protein A Detection, Easier and Faster Than ELISA
March 25th 2022A more streamlined technique with reduced hands-on time using the Octet® platform. For customers who require a sensitive and robust assay for measuring small amounts of leached Protein A in antibody or Fc-fusion protein samples.
Whitepaper: Titer and Protein Quantitation in as Little as Two Minutes
March 25th 2022Replace ELISA and HPLC with Octet® systems for quantitation of antibodies and recombinant therapeutic proteins. Accurate and fast assays are also easy to develop and transfer to QC and manufacturing. In this whitepaper you will learn about analyzing a full plate (96-samples) of IgG titer in as little as two minutes, assay directly in crude and unpurified samples, and automation for extending un-attended run times and high throughput analysis.